Fulgent Genetics, Inc. (NASDAQ:FLGT) appears in 174 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 2,774,519 | -187,715 | -6.34% | $44,114,850.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 1,289,000 | 583,973 | 82.83% | $20,495,100.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 1,233,951 | 48,061 | 4.05% | $19,602.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 880,150 | 880,150 | 0.00% | $13,994,385.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 671,664 | -217,348 | -24.45% | $10,678,638.00 |
| Invenomic Capital Management LP | 31 Mar, 2026 | 610,318 | 610,318 | 0.00% | $9,704,056.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 584,207 | 75,983 | 14.95% | $9,290,416.00 |
| Ameriprise Financial Inc | 31 Mar, 2026 | 563,375 | 63,864 | 12.79% | $8,957,663.00 |
| State Street Corp | 31 Mar, 2026 | 529,399 | 35,735 | 7.24% | $8,417,444.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 486,770 | -214,535 | -30.59% | $7,739,643.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 460,363 | 210,235 | 84.05% | $7,195,473.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 401,819 | -537,556 | -57.22% | $6,388,922.00 |
| Diametric Capital, LP | 31 Mar, 2026 | 361,046 | 160,886 | 80.38% | $5,740,631.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Mar, 2026 | 356,359 | 356,359 | 0.00% | $5,666,108.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 354,184 | -48,618 | -12.07% | $5,631,526.00 |
| DEUTSCHE BANK AG\ | 31 Mar, 2026 | 325,446 | -113,550 | -25.87% | $5,174,591.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 322,189 | 24,834 | 8.35% | $5,122,805.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 311,423 | -385,643 | -55.32% | $4,951,626.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Mar, 2026 | 302,564 | -72,261 | -19.28% | $4,810,768.00 |
| UBS Group AG | 31 Mar, 2026 | 240,759 | 157,200 | 188.13% | $3,828,068.00 |